Pages with the fewest revisions

Showing below up to 50 results in range #101 to #150.

101. Penile cancer‏‎ (1 revision)
102. 21. Left ventricular hypertrophy. Causes, sequential compensatory changes and functional consequences‏‎ (1 revision)
103. 47. The most important non-specific laboratory tests that suggest the presence of malignant diseases.‏‎ (1 revision)
104. 12. Development of the kidney and the urinary tract. Malformations‏‎ (1 revision)
105. 32. Epidemiology and prevention of infections transmitted through the skin‏‎ (1 revision)
106. Benign breast tumour‏‎ (1 revision)
107. Acute infectious thyroiditis‏‎ (1 revision)
108. 75. Antituberculotic drugs. Anti-leprosy drugs‏‎ (1 revision)
109. Pharma topics which are now ancient artifacts‏‎ (1 revision)
110. 22. Diuretic drugs‏‎ (1 revision)
111. 49. Congenital malformations, inflammations and tumors of the penis‏‎ (1 revision)
112. Herpes simplex virus infection‏‎ (1 revision)
113. 121. New and emerging risks in occupational medicine. Occupational diseases of health care workers and prevention. Occupational accidents.‏‎ (1 revision)
114. 33. Clinical signs of obstructions of the upper airways (upper airway stenosis), coniotomy, tracheotomy‏‎ (1 revision)
115. 8. Biological therapy, targeted therapy and immunotherapy‏‎ (1 revision)
116. 23. Acute tubular necrosis (ischaemic and toxic). Drug-induced (hypersensitive) interstitial nephritis, analgetic nephropathy, urate nephropathy. Acute and chronic pyelonephritis (pathogenesis, morphology, consequences and clinical course)‏‎ (1 revision)
117. Hypermagnesaemia‏‎ (1 revision)
118. 13. Epidemiology and prevention of lung cancer‏‎ (1 revision)
119. Burn injury‏‎ (1 revision)
120. 8. Trace elements‏‎ (1 revision)
121. Precancerous and malignant tumours of the oral cavity‏‎ (1 revision)
122. 5. The benign and malignant tumours of the stomach‏‎ (1 revision)
123. Hypophosphataemia‏‎ (1 revision)
124. 14. Complement system‏‎ (1 revision)
125. 34. Type III. and type IV. hypersensitivity reactions, related disorders‏‎ (1 revision)
126. Asplenism‏‎ (1 revision)
127. Protein Kinase C pathway‏‎ (1 revision)
128. 24. Laboratory monitoring of anticoagulant therapies.‏‎ (1 revision)
129. 51. Antiepileptic drugs‏‎ (1 revision)
130. 14. Tinnitus‏‎ (1 revision)
131. Cerebral palsy‏‎ (1 revision)
132. B10. Chronic pain treatment‏‎ (1 revision)
133. 9. Laboratory findings in respiratory type changes of the acid/base balance‏‎ (1 revision)
134. Rapidly Progressive Glomerulonephritis‏‎ (1 revision)
135. 25. General pathophysiology and classification of systemic hypertension – age and blood pressure‏‎ (1 revision)
136. 53. Chondromalacia patellae‏‎ (1 revision)
137. 15. Imaging of the liver and the hepatobiliary system. Imaging techniques, indications, information content.‏‎ (1 revision)
138. B13. Legal regulation of pregnancy interruption, methods and complications‏‎ (1 revision)
139. A1. Postoperative disturbances of wound healing‏‎ (1 revision)
140. Rosacea‏‎ (1 revision)
141. Knee deformities‏‎ (1 revision)
142. 26. Antihypertensive drugs‏‎ (1 revision)
143. 55. Chemical control of respiration. Acidosis, alkalosis‏‎ (1 revision)
144. 16. Cirrhosis. Causes, mechanisms and consequences. Hepatic cachexia.‏‎ (1 revision)
145. B16. Hormone replacement therapy guidelines, indications, contraindications, side effects‏‎ (1 revision)
146. A11. The routes of spread of malignant tumors‏‎ (1 revision)
147. Secondary hypertension‏‎ (1 revision)
148. Limb amputation‏‎ (1 revision)
149. 26. The sequence of events in the cardiac cycle‏‎ (1 revision)
150. 56. NRDS‏‎ (1 revision)